Mankind Pharma IPO Opens to a Slow Start, Subscribed Only 6% on Day 1
Day 1 subscription of Mankind Pharma IPO at 4%: Investors take a cautious approach
Mankind Pharma Aims To Raise Rs 4,700 crore through IPO
Mankind Pharma, backed by PE firm ChrysCapital, is in hopes to collect Rs 4,500-4,700 through an Initial Public Offering (IPO).
